| Adaptive randomization of veliparib–carboplatin treatment in breast cancer HS Rugo, OI Olopade, A DeMichele, C Yau, LJ van’t Veer, MB Buxton, ... New England Journal of Medicine 375 (1), 23-34, 2016 | 583 | 2016 |
| Adaptive randomization of neratinib in early breast cancer JW Park, MC Liu, D Yee, C Yau, LJ van’t Veer, WF Symmans, M Paoloni, ... New England Journal of Medicine 375 (1), 11-22, 2016 | 358 | 2016 |
| Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients C Yau, M Osdoit, M van der Noordaa, S Shad, J Wei, D de Croze, ... The Lancet Oncology 23 (1), 149-160, 2022 | 203 | 2022 |
| Radiation-induced sarcoma of the breast: a systematic review GR Sheth, LD Cranmer, BD Smith, L Grasso-LeBeau, JE Lang The oncologist 17 (3), 405-418, 2012 | 164 | 2012 |
| Genetically engineered cell-derived nanoparticles for targeted breast cancer immunotherapy X Shi, Q Cheng, T Hou, M Han, G Smbatyan, JE Lang, AL Epstein, ... Molecular therapy 28 (2), 536-547, 2020 | 158 | 2020 |
| Association of event-free and distant recurrence–free survival with individual-level pathologic complete response in neoadjuvant treatment of stages 2 and 3 breast cancer … D Yee, AM DeMichele, C Yau, C Isaacs, WF Symmans, KS Albain, ... JAMA oncology 6 (9), 1355-1362, 2020 | 140 | 2020 |
| Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts A Capasso, J Lang, TM Pitts, KR Jordan, CH Lieu, SL Davis, JR Diamond, ... Journal for immunotherapy of cancer 7, 1-16, 2019 | 137 | 2019 |
| Intraoperative frozen section analysis of sentinel lymph nodes in breast cancer patients: a meta‐analysis and single‐institution experience LC Liu, JE Lang, Y Lu, D Roe, SE Hwang, CA Ewing, LJ Esserman, ... Cancer 117 (2), 250-258, 2011 | 129 | 2011 |
| Oxidative stress, mammospheres and Nrf2–new implication for breast cancer therapy? T Wu, BG Harder, PK Wong, JE Lang, DD Zhang Molecular carcinogenesis 54 (11), 1494-1502, 2015 | 109 | 2015 |
| Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer JA Miller, JE Lang, M Ley, R Nagle, CH Hsu, PA Thompson, C Cordova, ... Cancer prevention research 6 (6), 577-584, 2013 | 109 | 2013 |
| HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer JE Lang, K Mosalpuria, M Cristofanilli, S Krishnamurthy, J Reuben, ... Breast cancer research and treatment 113, 501-507, 2009 | 107 | 2009 |
| Aminolevulinic acid (ALA): photodynamic detection and potential therapeutic applications B Nokes, M Apel, C Jones, G Brown, JE Lang Journal of surgical research 181 (2), 262-271, 2013 | 94 | 2013 |
| Primary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival JE Lang, W Tereffe, MP Mitchell, R Rao, L Feng, F Meric-Bernstam, ... Annals of surgical oncology 20, 1893-1899, 2013 | 88 | 2013 |
| Trends in post‐mastectomy reconstruction: A SEER database analysis JE Lang, DE Summers, H Cui, JN Carey, RK Viscusi, CA Hurst, AL Waer, ... Journal of surgical oncology 108 (3), 163-168, 2013 | 85 | 2013 |
| MK-2206 and standard neoadjuvant chemotherapy improves response in patients with human epidermal growth factor receptor 2–positive and/or hormone receptor–negative breast … AJ Chien, D Tripathy, KS Albain, WF Symmans, HS Rugo, ME Melisko, ... Journal of Clinical Oncology 38 (10), 1059, 2020 | 80 | 2020 |
| Breast ductal secretions: clinical features, potential uses, and possible applications JE Lang, HM Kuerer Cancer control 14 (4), 350-359, 2007 | 78 | 2007 |
| Ovarian cancer metastatic to the breast presenting as inflammatory breast cancer: a case report and literature review RL Klein, AR Brown, CM Gomez-Castro, SK Chambers, JM Cragun, ... Journal of Cancer 1, 27, 2010 | 71 | 2010 |
| Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation JE Lang, LJ Esserman, CA Ewing, HS Rugo, KT Lane, SP Leong, ... Journal of the American College of Surgeons 199 (6), 856-862, 2004 | 68 | 2004 |
| Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling GL Zoratti, LM Tanabe, FA Varela, AS Murray, C Bergum, É Colombo, ... Nature communications 6 (1), 6776, 2015 | 67 | 2015 |
| Complications of methylene blue dye in breast surgery: case reports and review of the literature FJ Reyes, MB Noelck, C Valentino, L Grasso-Lebeau, JE Lang Journal of Cancer 2, 20, 2011 | 63 | 2011 |
